Literature DB >> 8188708

Purification and partial characterization of 3-hydroxyisobutyryl-coenzyme A hydrolase of rat liver.

Y Shimomura1, T Murakami, N Fujitsuka, N Nakai, Y Sato, S Sugiyama, N Shimomura, J Irwin, J W Hawes, R A Harris.   

Abstract

An unusual feature of valine catabolism is a reaction in which an intermediate of its catabolic pathway, (S)-3-hydroxyisobutyryl-CoA, is hydrolyzed to give the free acid and CoA-SH. The enzyme responsible for this reaction, 3-hydroxyisobutyryl-CoA hydrolase (EC 3.1.2.4), was purified 7200-fold from rat liver in this study. The purified enzyme consists of a single polypeptide with an M(r) of 36,000 in the native and denatured forms. The hydrolase is highly specific for (S)-3-hydroxyisobutyryl-CoA and 3-hydroxypropionyl-CoA (Km, 6 and 25 microM, respectively) with optimal activity around pH 8. The turnover rate of the enzyme for (S)-3-hydroxyisobutyryl-CoA is 270 s-1, which is high relative to other enzymes of the valine pathway. Likewise, activity of the enzyme expressed on a wet weight basis is also very high in the major tissues of the rat. These findings suggest that rapid destruction of (S)-3-hydroxyisobutyryl-CoA produced during valine catabolism is physiologically important. We propose that the need for a mechanism to protect cells against the toxic effects of methacrylyl-CoA, which is maintained in equilibrium with (S)-3-hydroxyisobutyryl-CoA by crotonase, explains why valine catabolism involves this enzyme and why its tissue activity is so high.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8188708

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Genetic and genomic systems to study methylmalonic acidemia.

Authors:  R J Chandler; C P Venditti
Journal:  Mol Genet Metab       Date:  2005-09-22       Impact factor: 4.797

2.  Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer.

Authors:  Julie N Graff; Sachin Puri; Carlo B Bifulco; Bernard A Fox; Tomasz M Beer
Journal:  Cancer Immunol Res       Date:  2014-02-03       Impact factor: 11.151

3.  A Common Polymorphism in HIBCH Influences Methylmalonic Acid Concentrations in Blood Independently of Cobalamin.

Authors:  Anne M Molloy; Faith Pangilinan; James L Mills; Barry Shane; Mary B O'Neill; David M McGaughey; Aneliya Velkova; Hatice Ozel Abaan; Per M Ueland; Helene McNulty; Mary Ward; J J Strain; Conal Cunningham; Miriam Casey; Cheryl D Cropp; Yoonhee Kim; Joan E Bailey-Wilson; Alexander F Wilson; Lawrence C Brody
Journal:  Am J Hum Genet       Date:  2016-04-28       Impact factor: 11.025

4.  Candida albicans utilizes a modified β-oxidation pathway for the degradation of toxic propionyl-CoA.

Authors:  Christian Otzen; Bettina Bardl; Ilse D Jacobsen; Markus Nett; Matthias Brock
Journal:  J Biol Chem       Date:  2014-02-04       Impact factor: 5.157

5.  Enzymology of the branched-chain amino acid oxidation disorders: the valine pathway.

Authors:  Ronald J A Wanders; Marinus Duran; Ference J Loupatty
Journal:  J Inherit Metab Dis       Date:  2010-11-23       Impact factor: 4.982

6.  Clinical and biochemical characterization of four patients with mutations in ECHS1.

Authors:  Sacha Ferdinandusse; Marisa W Friederich; Alberto Burlina; Jos P N Ruiter; Curtis R Coughlin; Megan K Dishop; Renata C Gallagher; Jirair K Bedoyan; Frédéric M Vaz; Hans R Waterham; Katherine Gowan; Kathryn Chatfield; Kaitlyn Bloom; Michael J Bennett; Orly Elpeleg; Johan L K Van Hove; Ronald J A Wanders
Journal:  Orphanet J Rare Dis       Date:  2015-06-18       Impact factor: 4.123

7.  Screening of metagenomic and genomic libraries reveals three classes of bacterial enzymes that overcome the toxicity of acrylate.

Authors:  Andrew R J Curson; Oliver J Burns; Sonja Voget; Rolf Daniel; Jonathan D Todd; Kathryn McInnis; Margaret Wexler; Andrew W B Johnston
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

8.  Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis.

Authors:  Kenichiro Yamada; Misako Naiki; Shin Hoshino; Yasuyuki Kitaura; Yusuke Kondo; Noriko Nomura; Reiko Kimura; Daisuke Fukushi; Yasukazu Yamada; Nobuyuki Shimozawa; Seiji Yamaguchi; Yoshiharu Shimomura; Kiyokuni Miura; Nobuaki Wakamatsu
Journal:  Mol Genet Metab Rep       Date:  2014-10-16

9.  Cinical, Metabolic, and Genetic Analysis and Follow-Up of Eight Patients With HIBCH Mutations Presenting With Leigh/Leigh-Like Syndrome.

Authors:  Junling Wang; Zhimei Liu; Manting Xu; Xiaodi Han; Changhong Ren; Xinying Yang; Chunhua Zhang; Fang Fang
Journal:  Front Pharmacol       Date:  2021-03-08       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.